Diagnos Laboratorium Utama Tbk. vs Dian Swastatika Sentosa Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Dian Swastatika Sentosa Tbk trades at Rp990 (market cap 192.64T, 655.02M 24h volume). The key difference: Dian Swastatika Sentosa Tbk is far larger — about 609.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Dian Swastatika Sentosa Tbk is more actively traded (655.02M versus 41.7K). Which is the better fit depends on your goals.
| DGNS | DSSA | |
|---|---|---|
Market Cap | 316.25B | 192.64T |
Volume | 41.7K | 655.02M |
Lot | 417 | 6.55M |
Turnover | 9.66M | 649.58B |
Average Price | 231.65 | 991.7 |
Value | 9.66M | 649.58B |
Indicative Equilibrium Price | 230 | 990 |
Indicative Equilibrium Volume | 2.4K | 73.9K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Dian Swastatika Sentosa Tbk (the company) was established on August 2, 1996 based on Notarial Deed No. 6 and was amended by Notarial Deed No. 35 dated October 8, 1996, both of Linda Herawati, S.H., a public notary in Jakarta. The Company operates under the Sinarmas group of business.
Read more on DSSA →